Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Diversity of Hla Class I and Class Ii Alleles in Iran Populations: Systematic Review and Meta-Analaysis Publisher Pubmed



Abedini F1 ; Rahmanian N1, 2 ; Heidari Z3 ; Feizi A3 ; Sherkat R4 ; Rezaei M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Biostatistics and Epidemiology, School of Health, Isfahan University of Medical sciences, Isfahan, Iran
  4. 4. Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Transplant Immunology Published:2021


Abstract

The human leukocyte antigen (HLA) system plays an essential role in the peptides antigen presentation and more regulation of immune responses. Regarding all HLA molecules' associations with various diseases and their clinical utilities in understanding drug reactions or prediction of transplantation outcome, there is a need for much more extensive HLA data generated from Asian countries. Method: A comprehensive search was conducted in electronic databases between 1990 and 2021 to identify relevant articles to HLA frequency in the normal Iranian population. Two independent reviewers screened and selected the eligible studies. After data extraction, the meta-analysis was performed using STATA version 14. The overall frequencies and their 95% confidence intervals (CIs) were obtained using the random-effects model. Results: Among 1141 studies 78 were eligible for this study and the sample sizes varied from 14 to 15,600. The most frequent alleles of HLA class I were HLA-A*02 (22%; 95%CI: 20–24%; I2 = 88.63%), -B*35 (18%; 95%CI: 16–21%; I2 = 90.95%), -C*12 (18%; 95%CI: 13–22%; I2 = 89.51%). HLA-DQA1*01 (42%; 95%CI: 40–44%; I2 = 56.80%), -DQB1*03 (38%; 95%CI: 35–42%; I2 = 92.38%), and -DRB1*11 (24%; 95%CI: 22–26%; I2 = 90.72%) were the most frequent alleles of HLA class II in Iran. Discussion: Our meta-analysis results point out that the comprehensive report of HLA allele frequency in the Iranian population could be helpful as reference data for planning and managing transplantation and immune disease treatment in Iran. © 2021 Elsevier B.V.
Related Docs
1. Epidemiology of Multiple Sclerosis in Iran: A Systematic Review, European Neurology (2013)
2. Analysis of Hla Class I Alloantibodies in the Sera of Sensitized Patients on Hemodialysis, Archives of Iranian Medicine (2002)
3. An Investigation Into the Association Between Hla-G 14Bp Insertion/Deletion Polymorphism and Multiple Sclerosis Susceptibility, Journal of Neuroimmunology (2016)
4. Important Factors Influencing Severity of Common Variable Immunodeficiency, Archives of Iranian Medicine (2016)
5. Ongoing Increase in Incidence and Prevalence of Multiple Sclerosis in South-Eastern Iran: A Three Decade Study, Multiple Sclerosis and Related Disorders (2023)
6. The Involvement of the Hla-Dqb1 Alleles in the Risk and the Severity of Iranian Coeliac Disease Patients, International Journal of Immunogenetics (2014)
7. Association of Non-Hla Genes With Ankylosing Spondylitis, Ankylosing Spondylitis - Axial Spondyloarthritis: Cellular, Molecular and Environmental Factors (2021)
8. Association Between Serum Hla-G Levels in the First Trimester of Pregnancy and the Onset of Preeclampsia: A Systematic Review and Meta-Analysis Study, International Journal of Fertility and Sterility (2023)
Experts (# of related papers)
View all Related Experts
Masoud Etemadifar (2)
Mohammad Kazemi (1)